Cancer Gene Therapy: The Next Chapter
Perspectives from the Frontline
Tuesday, April 10 at 4pm – The Harvard Club of New York City
ACGT Fellow and Scientific Advisory Council Member, Carl H. June, MD, will be a keynote speaker along with a panel of leading scientists and biotechnology executives, including:
Usman “Oz” Azam, MD of Tmunity Therapeutics; George Yancopoulos, MD, PhD, President and Chief Scientific Officer of Regeneron; Mitchell Finer, MD, Managing Director of MPM Capital; and André Choulika, PhD, Chairman and Chief Executive Officer, Cellectis. Rachel Elliott, patient in Dr. Carl June’s CAR T immunotherapy clinical trial, will share her story.
The panel discussion will take place from 4-5:30 pm followed by a cocktail reception from 5:30-7 pm.
This event is open to the public, but space is limited. Tickets are $200 each and sponsorships are available.
For more information, call 203.358.5055 or email Barbara Gallagher.